ANI Pharmaceuticals Inc (ANIP)
Days of inventory on hand (DOH)
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inventory turnover | 3.62 | 3.51 | 3.31 | 3.19 | 3.02 | 3.26 | 3.11 | 3.10 | 2.47 | 2.39 | 1.71 | 1.42 | 1.43 | 1.36 | 1.43 | 1.33 | 1.31 | 1.42 | 1.46 | 1.60 | |
DOH | days | 100.71 | 104.05 | 110.13 | 114.25 | 120.98 | 111.88 | 117.54 | 117.87 | 147.69 | 152.69 | 213.04 | 256.31 | 254.63 | 268.69 | 254.80 | 274.93 | 278.36 | 257.34 | 250.14 | 228.79 |
December 31, 2023 calculation
DOH = 365 ÷ Inventory turnover
= 365 ÷ 3.62
= 100.71
The days of inventory on hand (DOH) for ANI Pharmaceuticals Inc have been fluctuating over the past eight quarters. From Q1 2022 to Q4 2023, the DOH ranged from 223.60 days to 277.08 days. The trend indicates a general increase in the number of days it takes for the company to sell its inventory, reaching a peak in Q4 2022 before showing some decrease in recent quarters. This suggests potential inefficiencies in inventory management or a build-up of excess inventory, which could tie up capital and lead to higher holding costs. ANI Pharmaceuticals Inc may benefit from implementing strategies to streamline its inventory turnover process and optimize its working capital management in order to improve its overall financial performance.
Peer comparison
Dec 31, 2023